Loading clinical trials...
Loading clinical trials...
A Single-Arm Phase II Clinical Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma
Conditions
Interventions
Biopsy
Biospecimen Collection
+6 more
Locations
1
United States
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States
Start Date
August 6, 2024
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2027
Last Updated
April 22, 2026
NCT06998940
NCT07240766
NCT06381154
NCT05825066
NCT05688215
NCT06649474
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions